Large Prevention Trial Shows Metformin Ineffective Against Age-Related Disease
The MET-PREVENT trial enrolled over 1,000 participants to test whether metformin could delay onset of cardiovascular disease, cancer, dementia, and other age-r…
Found 573 results for "cancer"
The MET-PREVENT trial enrolled over 1,000 participants to test whether metformin could delay onset of cardiovascular disease, cancer, dementia, and other age-r…
Scientists have engineered circular RNA structures that form self-looping configurations, demonstrating enhanced stability and prolonged therapeutic activity c…
French researchers have mapped the mechanisms by which mitochondria migrate between adjacent cells, particularly within tumor environments. This intercellular…
An international expert panel has established the first formal clinical definitions and assessment frameworks for loneliness specifically in older cancer patie…
The TROFFi trial represents a groundbreaking application of senolytic therapy, testing whether fisetin at 20 mg/kg daily can reverse chemotherapy-induced physi…
Researchers developed specialized liposomes containing triphenylphosphonium (TPP3) that successfully deliver resveratrol and Trolox antioxidants directly to mi…
vCATCH technology achieves single-cell resolution mapping of covalent drug binding sites across intact mammalian tissues, offering unprecedented visualization…
University of South Florida researchers identified elevated omega-6 fatty acid concentrations within colorectal tumor tissue, demonstrating a direct inflammato…
Trastuzumab deruxtecan demonstrated superior invasive disease-free survival compared to standard trastuzumab in patients with HER2-positive early breast cancer…
Clinical trial data reveals that time-limited chronic lymphocytic leukemia treatment produces equivalent survival outcomes compared to indefinite therapy regim…
The dual-drug approach combining trastuzumab deruxtecan with pertuzumab demonstrated enhanced progression-free survival compared to standard HER2-targeted ther…
Enzalutamide, an androgen receptor inhibitor, demonstrated significant survival benefits in men with biochemically recurrent prostate cancer following initial…
A compound initially identified in cancer drug screening has demonstrated dual efficacy against Huntington's disease pathology and calcium oxalate kidney stone…